Juan Andres - 14 Mar 2022 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role: Chief Technical Operations and Quality Officer
Signature: /s/ Brian Sandstrom, as Attorney-in-Fact
Issuer symbol: MRNA
Transactions as of: 14 Mar 2022
Net transactions value: -$271,560
Form type: 4
Filing time: 15 Mar 2022, 16:19:06 UTC
Previous filing: 03 Mar 2022
Next filing: 18 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRNA	Common Stock	Options Exercise	$28,440	+2,000	+22%	$14.22^*	11,069	14 Mar 2022	Direct	F1
transaction	MRNA	Common Stock	Sale	$300,000	-2,000	-18%	$150.00	9,069	14 Mar 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRNA	Stock Option (Right to Buy)	Options Exercise	$0	-2,000	-11%	$0.000000	16,629	14 Mar 2022	Common Stock	2,000	$14.22	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 19, 2021.
F2	This option is fully vested and exercisable.

Remarks:

Chief Technical Operations and Quality Officer